about
Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomitingPalonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy.Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVOral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.Exploring Chemotherapy-Induced Toxicities through Multivariate Projection of Risk Factors: Prediction of Nausea and VomitingAntiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients.Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.Olanzapine for nausea and vomiting.Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
P2860
Q28258863-72B28660-6C70-4394-991A-F9122931B082Q34418467-983D1F26-4AFD-4FD0-B14C-00C494B2B5AFQ36616499-EFF2CF51-8402-4328-AAE9-4E593D3E4C1AQ36937565-4F80C30A-A1FD-4A67-9124-4B82492E39C0Q37038999-BD3E6623-16ED-44E0-BA35-AA0DE8CAD679Q37316977-0D59AA6F-0A24-49DA-8ABB-9379E1DA274FQ37326382-701BAD6A-541E-47E3-995D-B9E61D79226AQ37355479-970FD229-1588-48D9-A777-82D226FFB448Q37636028-3F1C8CA9-EB0D-450B-8B50-7338B25038CCQ37760068-FAB3C41E-7B04-43A1-B801-6729090946DBQ37761263-578666CC-255B-4CDA-B16A-326D4800B611Q37771953-951F01DC-DA8A-4391-A7EA-598138411E20
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Emerging drugs for chemotherapy-induced emesis.
@ast
Emerging drugs for chemotherapy-induced emesis.
@en
type
label
Emerging drugs for chemotherapy-induced emesis.
@ast
Emerging drugs for chemotherapy-induced emesis.
@en
prefLabel
Emerging drugs for chemotherapy-induced emesis.
@ast
Emerging drugs for chemotherapy-induced emesis.
@en
P2860
P1476
Emerging drugs for chemotherapy-induced emesis.
@en
P2093
Paula S Province
Rudolph M Navari
P2860
P304
P356
10.1517/14728214.11.1.137
P407
P577
2006-03-01T00:00:00Z